Online inquiry

IVTScrip™ mRNA-Human AES, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK8977MR)

This product GTTS-WK8977MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the AES protein. This product can be used in Mitotic arrest phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001130.6
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 166
UniProt ID Q08117
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AES, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK8977MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK18539MR IVTScrip™ mRNA-Human ANKS4B, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANKS4B
GTTS-WK17003MR IVTScrip™ mRNA-Human ANKRD17, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ANKRD17
GTTS-WK20003MR IVTScrip™ mRNA-Human ANKRD17, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD17
GTTS-WK20308MR IVTScrip™ mRNA-Human ANKRD20A4, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ANKRD20A4
GTTS-WK10144MR IVTScrip™ mRNA-Human ADGRG6, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ADGRG6
GTTS-WK22557MR IVTScrip™ mRNA-Human ARAP2, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ARAP2
GTTS-WK28628MR IVTScrip™ mRNA-Human ARID5B, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARID5B
GTTS-WK15532MR IVTScrip™ mRNA-Human ANKRD6, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ANKRD6
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →